NY Ins L § 213 (2021)
2021 New York Laws ISC - Insurance Article 2 - Organization of the Department of Financial Services 213 - New York State Health Care Quality and Cost Containment Commission.

§  213.  New  York  state  health  care  quality  and cost containment commission. (a) There is hereby  established  within  the  department  a commission,  to  be known as the "New York state health care quality and cost containment commission". The commission shall consist  of  thirteen members   appointed   by   the  governor,  one  of  whom  shall  be  the superintendent, one of whom shall be the commissioner of health, and six of whom shall be appointed on  the  recommendation  of  the  legislative leaders,  two  on  the  recommendation of the temporary president of the senate, two on the recommendation of the speaker of the assembly, one on the recommendation of the minority leader of the senate, and one on  the recommendation of the minority leader of the assembly. All members shall serve  at the pleasure of the governor, and vacancies shall be appointed in the same manner as original appointments. Members of  the  commission shall serve without compensation, but shall be reimbursed for reasonable travel  expenses. In making appointments to the commission, the governor shall  ensure  that  the  interests  of  health  care  consumers,  small businesses,  the  medical  community and health plans are represented on the commission.  (b)(1) The purpose of the commission shall be to analyze the impact on health insurance costs and quality of proposed legislation  which  would mandate  that health benefits be offered or made available in individual and group health insurance policies, contracts and comprehensive  health service plans, including legislation that affects the delivery of health benefits or services or the reimbursement of health care providers.  (2)  The governor, the chair of the senate insurance committee and the chair of the assembly insurance committee may request  in  writing  that the commission evaluate a proposed mandated benefit. Upon receiving such a  request,  the  commission  may,  by  a  majority vote of its members, undertake an evaluation of such proposed mandated benefit.  (3) In evaluating a proposed mandated benefit, the commission shall:  (A) investigate the current practices of health plans with  regard  to the  proposed mandated benefit, and, to the extent possible, self-funded health benefit plans;  (B) investigate the potential premium impact of the proposed  mandated benefits  on  all  segments  of  the  insurance  market,  as well as the potential for avoided costs through early  detection  and  treatment  of conditions, or more cost-effective delivery of medical services; and  (C) analyze the most current medical literature regarding the proposed mandated benefit to determine its impact on health care quality.  (4) In evaluating a proposed mandated benefit, the commission may hold one  or more public hearings, and shall strive to obtain independent and verifiable  information  from  diverse  sources  within  the  healthcare industry,  medical community and among health care consumers with regard to the proposed mandated benefit.  (c) To assist the commission in its duties, and upon the direction  of the  commission,  the  superintendent is authorized to enter into one or more  contracts  with  independent  entities  and   organizations   with demonstrable  expertise in health care quality, finance, utilization and actuarial services. For the purposes of this section, the superintendent shall  not  enter  into  contracts  with  health  plans,   entities   or organizations  owned  or controlled by health plans, or with significant business relationships with health plans.  (d) Upon completion of its evaluation of a proposed  mandated  benefit pursuant  to this section, the commission shall deliver a written report of its findings to the chair of the assembly insurance committee and the chair of the senate insurance committee.